Global Veterinary Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, The global Veterinary Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Veterinary Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Veterinary Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Veterinary Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Veterinary Vaccine sales, projected growth trends, production technology, application and end-user industry.
Veterinary Vaccine segment by Company
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Veterinary Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Veterinary Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Veterinary Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Veterinary Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 VETERINARY VACCINE MARKET BY MANUFACTURERS
3.1 Global Veterinary Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Veterinary Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Veterinary Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Veterinary Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
3.7 Global Veterinary Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
4 VETERINARY VACCINE MARKET BY TYPE
4.1 Veterinary Vaccine Type Introduction
4.1.1 Live Attenuated Vaccines
4.1.2 Inactivated Vaccines
4.1.3 Others
4.2 Global Veterinary Vaccine Sales by Type
4.2.1 Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales by Type (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Revenue by Type
4.3.1 Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
4.3.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
5 VETERINARY VACCINE MARKET BY APPLICATION
5.1 Veterinary Vaccine Application Introduction
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Sales by Application
5.2.1 Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales by Application (2019-2030)
5.2.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Revenue by Application
5.3.1 Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
5.3.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL VETERINARY VACCINE SALES BY REGION
6.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Veterinary Vaccine Sales by Region (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Region (2019-2024)
6.2.2 Global Veterinary Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Veterinary Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Veterinary Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Veterinary Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL VETERINARY VACCINE REVENUE BY REGION
7.1 Global Veterinary Vaccine Revenue by Region
7.1.1 Global Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Veterinary Vaccine Revenue by Region (2019-2024)
7.1.3 Global Veterinary Vaccine Revenue by Region (2025-2030)
7.1.4 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Veterinary Vaccine Revenue (2019-2030)
7.2.2 North America Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Veterinary Vaccine Revenue (2019-2030)
7.3.2 Europe Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Veterinary Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Veterinary Vaccine Revenue (2019-2030)
7.5.2 LAMEA Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Veterinary Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Zoetis
8.2.1 Zoetis Comapny Information
8.2.2 Zoetis Business Overview
8.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Zoetis Veterinary Vaccine Product Portfolio
8.2.5 Zoetis Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Ceva
8.4.1 Ceva Comapny Information
8.4.2 Ceva Business Overview
8.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ceva Veterinary Vaccine Product Portfolio
8.4.5 Ceva Recent Developments
8.5 CAHIC
8.5.1 CAHIC Comapny Information
8.5.2 CAHIC Business Overview
8.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CAHIC Veterinary Vaccine Product Portfolio
8.5.5 CAHIC Recent Developments
8.6 HVRI
8.6.1 HVRI Comapny Information
8.6.2 HVRI Business Overview
8.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 HVRI Veterinary Vaccine Product Portfolio
8.6.5 HVRI Recent Developments
8.7 Ringpu Biology
8.7.1 Ringpu Biology Comapny Information
8.7.2 Ringpu Biology Business Overview
8.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
8.7.5 Ringpu Biology Recent Developments
8.8 Yebio
8.8.1 Yebio Comapny Information
8.8.2 Yebio Business Overview
8.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Yebio Veterinary Vaccine Product Portfolio
8.8.5 Yebio Recent Developments
8.9 DHN
8.9.1 DHN Comapny Information
8.9.2 DHN Business Overview
8.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 DHN Veterinary Vaccine Product Portfolio
8.9.5 DHN Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 WINSUN Veterinary Vaccine Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Elanco Veterinary Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Virbac
8.12.1 Virbac Comapny Information
8.12.2 Virbac Business Overview
8.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Virbac Veterinary Vaccine Product Portfolio
8.12.5 Virbac Recent Developments
8.13 Jinyu Bio-Technology
8.13.1 Jinyu Bio-Technology Comapny Information
8.13.2 Jinyu Bio-Technology Business Overview
8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
8.13.5 Jinyu Bio-Technology Recent Developments
8.14 ChengDu Tecbond
8.14.1 ChengDu Tecbond Comapny Information
8.14.2 ChengDu Tecbond Business Overview
8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
8.14.5 ChengDu Tecbond Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CAVAC Veterinary Vaccine Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Kyoto Biken Laboratories
8.16.1 Kyoto Biken Laboratories Comapny Information
8.16.2 Kyoto Biken Laboratories Business Overview
8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
8.16.5 Kyoto Biken Laboratories Recent Developments
8.17 FATRO
8.17.1 FATRO Comapny Information
8.17.2 FATRO Business Overview
8.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 FATRO Veterinary Vaccine Product Portfolio
8.17.5 FATRO Recent Developments
8.18 Vaksindo
8.18.1 Vaksindo Comapny Information
8.18.2 Vaksindo Business Overview
8.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
8.18.5 Vaksindo Recent Developments
8.19 Bio-Labs
8.19.1 Bio-Labs Comapny Information
8.19.2 Bio-Labs Business Overview
8.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
8.19.5 Bio-Labs Recent Developments
8.20 Avimex Animal Health
8.20.1 Avimex Animal Health Comapny Information
8.20.2 Avimex Animal Health Business Overview
8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
8.20.5 Avimex Animal Health Recent Developments
8.21 MEVAC
8.21.1 MEVAC Comapny Information
8.21.2 MEVAC Business Overview
8.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.21.4 MEVAC Veterinary Vaccine Product Portfolio
8.21.5 MEVAC Recent Developments
8.22 Biovac
8.22.1 Biovac Comapny Information
8.22.2 Biovac Business Overview
8.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.22.4 Biovac Veterinary Vaccine Product Portfolio
8.22.5 Biovac Recent Developments
8.23 Atafen
8.23.1 Atafen Comapny Information
8.23.2 Atafen Business Overview
8.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.23.4 Atafen Veterinary Vaccine Product Portfolio
8.23.5 Atafen Recent Developments
8.24 Dyntec
8.24.1 Dyntec Comapny Information
8.24.2 Dyntec Business Overview
8.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.24.4 Dyntec Veterinary Vaccine Product Portfolio
8.24.5 Dyntec Recent Developments
8.25 BioTestLab
8.25.1 BioTestLab Comapny Information
8.25.2 BioTestLab Business Overview
8.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
8.25.5 BioTestLab Recent Developments
8.26 RVSRI
8.26.1 RVSRI Comapny Information
8.26.2 RVSRI Business Overview
8.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.26.4 RVSRI Veterinary Vaccine Product Portfolio
8.26.5 RVSRI Recent Developments
8.27 Medion
8.27.1 Medion Comapny Information
8.27.2 Medion Business Overview
8.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.27.4 Medion Veterinary Vaccine Product Portfolio
8.27.5 Medion Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Veterinary Vaccine Value Chain Analysis
9.1.1 Veterinary Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Veterinary Vaccine Production Mode & Process
9.2 Veterinary Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Veterinary Vaccine Distributors
9.2.3 Veterinary Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Veterinary Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Veterinary Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Veterinary Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Veterinary Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL VETERINARY VACCINE MARKET DYNAMICS
2.1 Veterinary Vaccine Industry Trends
2.2 Veterinary Vaccine Industry Drivers
2.3 Veterinary Vaccine Industry Opportunities and Challenges
2.4 Veterinary Vaccine Industry Restraints
3 VETERINARY VACCINE MARKET BY MANUFACTURERS
3.1 Global Veterinary Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Veterinary Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Veterinary Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Veterinary Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Veterinary Vaccine Manufacturers, Product Type & Application
3.7 Global Veterinary Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Veterinary Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Veterinary Vaccine Tier 1, Tier 2, and Tier
4 VETERINARY VACCINE MARKET BY TYPE
4.1 Veterinary Vaccine Type Introduction
4.1.1 Live Attenuated Vaccines
4.1.2 Inactivated Vaccines
4.1.3 Others
4.2 Global Veterinary Vaccine Sales by Type
4.2.1 Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Veterinary Vaccine Sales by Type (2019-2030)
4.2.3 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Veterinary Vaccine Revenue by Type
4.3.1 Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
4.3.3 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
5 VETERINARY VACCINE MARKET BY APPLICATION
5.1 Veterinary Vaccine Application Introduction
5.1.1 Livestock
5.1.2 Swine
5.1.3 Chicken
5.1.4 Dog & Cat
5.1.5 Others
5.2 Global Veterinary Vaccine Sales by Application
5.2.1 Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Veterinary Vaccine Sales by Application (2019-2030)
5.2.3 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Veterinary Vaccine Revenue by Application
5.3.1 Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
5.3.3 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL VETERINARY VACCINE SALES BY REGION
6.1 Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Veterinary Vaccine Sales by Region (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Region (2019-2024)
6.2.2 Global Veterinary Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Veterinary Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Veterinary Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Veterinary Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL VETERINARY VACCINE REVENUE BY REGION
7.1 Global Veterinary Vaccine Revenue by Region
7.1.1 Global Veterinary Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Veterinary Vaccine Revenue by Region (2019-2024)
7.1.3 Global Veterinary Vaccine Revenue by Region (2025-2030)
7.1.4 Global Veterinary Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Veterinary Vaccine Revenue (2019-2030)
7.2.2 North America Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Veterinary Vaccine Revenue (2019-2030)
7.3.2 Europe Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Veterinary Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Veterinary Vaccine Revenue (2019-2030)
7.5.2 LAMEA Veterinary Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Veterinary Vaccine Product Portfolio
8.1.5 Merck Recent Developments
8.2 Zoetis
8.2.1 Zoetis Comapny Information
8.2.2 Zoetis Business Overview
8.2.3 Zoetis Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Zoetis Veterinary Vaccine Product Portfolio
8.2.5 Zoetis Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Ceva
8.4.1 Ceva Comapny Information
8.4.2 Ceva Business Overview
8.4.3 Ceva Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Ceva Veterinary Vaccine Product Portfolio
8.4.5 Ceva Recent Developments
8.5 CAHIC
8.5.1 CAHIC Comapny Information
8.5.2 CAHIC Business Overview
8.5.3 CAHIC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CAHIC Veterinary Vaccine Product Portfolio
8.5.5 CAHIC Recent Developments
8.6 HVRI
8.6.1 HVRI Comapny Information
8.6.2 HVRI Business Overview
8.6.3 HVRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 HVRI Veterinary Vaccine Product Portfolio
8.6.5 HVRI Recent Developments
8.7 Ringpu Biology
8.7.1 Ringpu Biology Comapny Information
8.7.2 Ringpu Biology Business Overview
8.7.3 Ringpu Biology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
8.7.5 Ringpu Biology Recent Developments
8.8 Yebio
8.8.1 Yebio Comapny Information
8.8.2 Yebio Business Overview
8.8.3 Yebio Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Yebio Veterinary Vaccine Product Portfolio
8.8.5 Yebio Recent Developments
8.9 DHN
8.9.1 DHN Comapny Information
8.9.2 DHN Business Overview
8.9.3 DHN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 DHN Veterinary Vaccine Product Portfolio
8.9.5 DHN Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 WINSUN Veterinary Vaccine Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Elanco
8.11.1 Elanco Comapny Information
8.11.2 Elanco Business Overview
8.11.3 Elanco Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Elanco Veterinary Vaccine Product Portfolio
8.11.5 Elanco Recent Developments
8.12 Virbac
8.12.1 Virbac Comapny Information
8.12.2 Virbac Business Overview
8.12.3 Virbac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Virbac Veterinary Vaccine Product Portfolio
8.12.5 Virbac Recent Developments
8.13 Jinyu Bio-Technology
8.13.1 Jinyu Bio-Technology Comapny Information
8.13.2 Jinyu Bio-Technology Business Overview
8.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
8.13.5 Jinyu Bio-Technology Recent Developments
8.14 ChengDu Tecbond
8.14.1 ChengDu Tecbond Comapny Information
8.14.2 ChengDu Tecbond Business Overview
8.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
8.14.5 ChengDu Tecbond Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CAVAC Veterinary Vaccine Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Kyoto Biken Laboratories
8.16.1 Kyoto Biken Laboratories Comapny Information
8.16.2 Kyoto Biken Laboratories Business Overview
8.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
8.16.5 Kyoto Biken Laboratories Recent Developments
8.17 FATRO
8.17.1 FATRO Comapny Information
8.17.2 FATRO Business Overview
8.17.3 FATRO Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 FATRO Veterinary Vaccine Product Portfolio
8.17.5 FATRO Recent Developments
8.18 Vaksindo
8.18.1 Vaksindo Comapny Information
8.18.2 Vaksindo Business Overview
8.18.3 Vaksindo Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Vaksindo Veterinary Vaccine Product Portfolio
8.18.5 Vaksindo Recent Developments
8.19 Bio-Labs
8.19.1 Bio-Labs Comapny Information
8.19.2 Bio-Labs Business Overview
8.19.3 Bio-Labs Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
8.19.5 Bio-Labs Recent Developments
8.20 Avimex Animal Health
8.20.1 Avimex Animal Health Comapny Information
8.20.2 Avimex Animal Health Business Overview
8.20.3 Avimex Animal Health Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
8.20.5 Avimex Animal Health Recent Developments
8.21 MEVAC
8.21.1 MEVAC Comapny Information
8.21.2 MEVAC Business Overview
8.21.3 MEVAC Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.21.4 MEVAC Veterinary Vaccine Product Portfolio
8.21.5 MEVAC Recent Developments
8.22 Biovac
8.22.1 Biovac Comapny Information
8.22.2 Biovac Business Overview
8.22.3 Biovac Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.22.4 Biovac Veterinary Vaccine Product Portfolio
8.22.5 Biovac Recent Developments
8.23 Atafen
8.23.1 Atafen Comapny Information
8.23.2 Atafen Business Overview
8.23.3 Atafen Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.23.4 Atafen Veterinary Vaccine Product Portfolio
8.23.5 Atafen Recent Developments
8.24 Dyntec
8.24.1 Dyntec Comapny Information
8.24.2 Dyntec Business Overview
8.24.3 Dyntec Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.24.4 Dyntec Veterinary Vaccine Product Portfolio
8.24.5 Dyntec Recent Developments
8.25 BioTestLab
8.25.1 BioTestLab Comapny Information
8.25.2 BioTestLab Business Overview
8.25.3 BioTestLab Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.25.4 BioTestLab Veterinary Vaccine Product Portfolio
8.25.5 BioTestLab Recent Developments
8.26 RVSRI
8.26.1 RVSRI Comapny Information
8.26.2 RVSRI Business Overview
8.26.3 RVSRI Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.26.4 RVSRI Veterinary Vaccine Product Portfolio
8.26.5 RVSRI Recent Developments
8.27 Medion
8.27.1 Medion Comapny Information
8.27.2 Medion Business Overview
8.27.3 Medion Veterinary Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.27.4 Medion Veterinary Vaccine Product Portfolio
8.27.5 Medion Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Veterinary Vaccine Value Chain Analysis
9.1.1 Veterinary Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Veterinary Vaccine Production Mode & Process
9.2 Veterinary Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Veterinary Vaccine Distributors
9.2.3 Veterinary Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Veterinary Vaccine Industry Trends
Table 2. Veterinary Vaccine Industry Drivers
Table 3. Veterinary Vaccine Industry Opportunities and Challenges
Table 4. Veterinary Vaccine Industry Restraints
Table 5. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Veterinary Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Veterinary Vaccine Sales Market Share by Manufacturers
Table 9. Global Veterinary Vaccine Average Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 10. Global Veterinary Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Veterinary Vaccine Manufacturers, Product Type & Application
Table 13. Global Veterinary Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Live Attenuated Vaccines
Table 17. Major Manufacturers of Inactivated Vaccines
Table 18. Major Manufacturers of Others
Table 19. Global Veterinary Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 22. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 23. Global Veterinary Vaccine Sales Market Share by Type (2025-2030)
Table 24. Global Veterinary Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 25. Global Veterinary Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 26. Global Veterinary Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 27. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 28. Global Veterinary Vaccine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Livestock
Table 30. Major Manufacturers of Swine
Table 31. Major Manufacturers of Chicken
Table 32. Major Manufacturers of Dog & Cat
Table 33. Major Manufacturers of Others
Table 34. Global Veterinary Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 35. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 36. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 37. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 38. Global Veterinary Vaccine Sales Market Share by Application (2025-2030)
Table 39. Global Veterinary Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 40. Global Veterinary Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 41. Global Veterinary Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 42. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 43. Global Veterinary Vaccine Revenue Market Share by Application (2025-2030)
Table 44. Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 45. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 46. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 47. Global Veterinary Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 48. Global Veterinary Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 49. North America Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. North America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 51. North America Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 52. Europe Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 54. Europe Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 55. Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. Asia Pacific Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. Asia Pacific Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. LAMEA Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 59. LAMEA Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 60. LAMEA Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 61. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 62. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 63. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 64. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 65. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
Table 66. Merck Company Information
Table 67. Merck Business Overview
Table 68. Merck Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Merck Veterinary Vaccine Product Portfolio
Table 70. Merck Recent Development
Table 71. Zoetis Company Information
Table 72. Zoetis Business Overview
Table 73. Zoetis Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Zoetis Veterinary Vaccine Product Portfolio
Table 75. Zoetis Recent Development
Table 76. Boehringer Ingelheim Company Information
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 80. Boehringer Ingelheim Recent Development
Table 81. Ceva Company Information
Table 82. Ceva Business Overview
Table 83. Ceva Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Ceva Veterinary Vaccine Product Portfolio
Table 85. Ceva Recent Development
Table 86. CAHIC Company Information
Table 87. CAHIC Business Overview
Table 88. CAHIC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. CAHIC Veterinary Vaccine Product Portfolio
Table 90. CAHIC Recent Development
Table 91. HVRI Company Information
Table 92. HVRI Business Overview
Table 93. HVRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. HVRI Veterinary Vaccine Product Portfolio
Table 95. HVRI Recent Development
Table 96. Ringpu Biology Company Information
Table 97. Ringpu Biology Business Overview
Table 98. Ringpu Biology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 99. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 100. Ringpu Biology Recent Development
Table 101. Yebio Company Information
Table 102. Yebio Business Overview
Table 103. Yebio Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 104. Yebio Veterinary Vaccine Product Portfolio
Table 105. Yebio Recent Development
Table 106. DHN Company Information
Table 107. DHN Business Overview
Table 108. DHN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 109. DHN Veterinary Vaccine Product Portfolio
Table 110. DHN Recent Development
Table 111. WINSUN Company Information
Table 112. WINSUN Business Overview
Table 113. WINSUN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 114. WINSUN Veterinary Vaccine Product Portfolio
Table 115. WINSUN Recent Development
Table 116. Elanco Company Information
Table 117. Elanco Business Overview
Table 118. Elanco Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 119. Elanco Veterinary Vaccine Product Portfolio
Table 120. Elanco Recent Development
Table 121. Virbac Company Information
Table 122. Virbac Business Overview
Table 123. Virbac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 124. Virbac Veterinary Vaccine Product Portfolio
Table 125. Virbac Recent Development
Table 126. Jinyu Bio-Technology Company Information
Table 127. Jinyu Bio-Technology Business Overview
Table 128. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 129. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 130. Jinyu Bio-Technology Recent Development
Table 131. ChengDu Tecbond Company Information
Table 132. ChengDu Tecbond Business Overview
Table 133. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 134. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 135. ChengDu Tecbond Recent Development
Table 136. CAVAC Company Information
Table 137. CAVAC Business Overview
Table 138. CAVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 139. CAVAC Veterinary Vaccine Product Portfolio
Table 140. CAVAC Recent Development
Table 141. Kyoto Biken Laboratories Company Information
Table 142. Kyoto Biken Laboratories Business Overview
Table 143. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 144. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 145. Kyoto Biken Laboratories Recent Development
Table 146. FATRO Company Information
Table 147. FATRO Business Overview
Table 148. FATRO Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 149. FATRO Veterinary Vaccine Product Portfolio
Table 150. FATRO Recent Development
Table 151. Vaksindo Company Information
Table 152. Vaksindo Business Overview
Table 153. Vaksindo Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 154. Vaksindo Veterinary Vaccine Product Portfolio
Table 155. Vaksindo Recent Development
Table 156. Bio-Labs Company Information
Table 157. Bio-Labs Business Overview
Table 158. Bio-Labs Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 159. Bio-Labs Veterinary Vaccine Product Portfolio
Table 160. Bio-Labs Recent Development
Table 161. Avimex Animal Health Company Information
Table 162. Avimex Animal Health Business Overview
Table 163. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 164. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 165. Avimex Animal Health Recent Development
Table 166. MEVAC Company Information
Table 167. MEVAC Business Overview
Table 168. MEVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 169. MEVAC Veterinary Vaccine Product Portfolio
Table 170. MEVAC Recent Development
Table 171. Biovac Company Information
Table 172. Biovac Business Overview
Table 173. Biovac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 174. Biovac Veterinary Vaccine Product Portfolio
Table 175. Biovac Recent Development
Table 176. Atafen Company Information
Table 177. Atafen Business Overview
Table 178. Atafen Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 179. Atafen Veterinary Vaccine Product Portfolio
Table 180. Atafen Recent Development
Table 181. Dyntec Company Information
Table 182. Dyntec Business Overview
Table 183. Dyntec Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 184. Dyntec Veterinary Vaccine Product Portfolio
Table 185. Dyntec Recent Development
Table 186. BioTestLab Company Information
Table 187. BioTestLab Business Overview
Table 188. BioTestLab Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 189. BioTestLab Veterinary Vaccine Product Portfolio
Table 190. BioTestLab Recent Development
Table 191. RVSRI Company Information
Table 192. RVSRI Business Overview
Table 193. RVSRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 194. RVSRI Veterinary Vaccine Product Portfolio
Table 195. RVSRI Recent Development
Table 196. Medion Company Information
Table 197. Medion Business Overview
Table 198. Medion Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 199. Medion Veterinary Vaccine Product Portfolio
Table 200. Medion Recent Development
Table 201. Key Raw Materials
Table 202. Raw Materials Key Suppliers
Table 203. Veterinary Vaccine Distributors List
Table 204. Veterinary Vaccine Customers List
Table 205. Research Programs/Design for This Report
Table 206. Authors List of This Report
Table 207. Secondary Sources
Table 208. Primary Sources
Table 1. Veterinary Vaccine Industry Trends
Table 2. Veterinary Vaccine Industry Drivers
Table 3. Veterinary Vaccine Industry Opportunities and Challenges
Table 4. Veterinary Vaccine Industry Restraints
Table 5. Global Veterinary Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Veterinary Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Veterinary Vaccine Sales by Manufacturers (M Doses) & (2019-2024)
Table 8. Global Veterinary Vaccine Sales Market Share by Manufacturers
Table 9. Global Veterinary Vaccine Average Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 10. Global Veterinary Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Veterinary Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Veterinary Vaccine Manufacturers, Product Type & Application
Table 13. Global Veterinary Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Live Attenuated Vaccines
Table 17. Major Manufacturers of Inactivated Vaccines
Table 18. Major Manufacturers of Others
Table 19. Global Veterinary Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Veterinary Vaccine Sales by Type (2019-2024) & (M Doses)
Table 21. Global Veterinary Vaccine Sales by Type (2025-2030) & (M Doses)
Table 22. Global Veterinary Vaccine Sales Market Share by Type (2019-2024)
Table 23. Global Veterinary Vaccine Sales Market Share by Type (2025-2030)
Table 24. Global Veterinary Vaccine Revenue by Type 2019 VS 2023 VS 2030 (M Doses)
Table 25. Global Veterinary Vaccine Revenue by Type (2019-2024) & (M Doses)
Table 26. Global Veterinary Vaccine Revenue by Type (2025-2030) & (M Doses)
Table 27. Global Veterinary Vaccine Revenue Market Share by Type (2019-2024)
Table 28. Global Veterinary Vaccine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Livestock
Table 30. Major Manufacturers of Swine
Table 31. Major Manufacturers of Chicken
Table 32. Major Manufacturers of Dog & Cat
Table 33. Major Manufacturers of Others
Table 34. Global Veterinary Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 35. Global Veterinary Vaccine Sales by Application (2019-2024) & (M Doses)
Table 36. Global Veterinary Vaccine Sales by Application (2025-2030) & (M Doses)
Table 37. Global Veterinary Vaccine Sales Market Share by Application (2019-2024)
Table 38. Global Veterinary Vaccine Sales Market Share by Application (2025-2030)
Table 39. Global Veterinary Vaccine Revenue by Application 2019 VS 2023 VS 2030 (M Doses)
Table 40. Global Veterinary Vaccine Revenue by Application (2019-2024) & (M Doses)
Table 41. Global Veterinary Vaccine Revenue by Application (2025-2030) & (M Doses)
Table 42. Global Veterinary Vaccine Revenue Market Share by Application (2019-2024)
Table 43. Global Veterinary Vaccine Revenue Market Share by Application (2025-2030)
Table 44. Global Veterinary Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 45. Global Veterinary Vaccine Sales by Region (2019-2024) & (M Doses)
Table 46. Global Veterinary Vaccine Sales Market Share by Region (2019-2024)
Table 47. Global Veterinary Vaccine Sales Forecasted by Region (2025-2030) & (M Doses)
Table 48. Global Veterinary Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 49. North America Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 50. North America Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 51. North America Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 52. Europe Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 53. Europe Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 54. Europe Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 55. Asia Pacific Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 56. Asia Pacific Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. Asia Pacific Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 58. LAMEA Veterinary Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 59. LAMEA Veterinary Vaccine Sales by Country (2019-2024) & (M Doses)
Table 60. LAMEA Veterinary Vaccine Sales by Country (2025-2030) & (M Doses)
Table 61. Global Veterinary Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 62. Global Veterinary Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 63. Global Veterinary Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 64. Global Veterinary Vaccine Revenue Market Share by Region (2019-2024)
Table 65. Global Veterinary Vaccine Revenue Market Share by Region (2025-2030)
Table 66. Merck Company Information
Table 67. Merck Business Overview
Table 68. Merck Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Merck Veterinary Vaccine Product Portfolio
Table 70. Merck Recent Development
Table 71. Zoetis Company Information
Table 72. Zoetis Business Overview
Table 73. Zoetis Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Zoetis Veterinary Vaccine Product Portfolio
Table 75. Zoetis Recent Development
Table 76. Boehringer Ingelheim Company Information
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 80. Boehringer Ingelheim Recent Development
Table 81. Ceva Company Information
Table 82. Ceva Business Overview
Table 83. Ceva Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Ceva Veterinary Vaccine Product Portfolio
Table 85. Ceva Recent Development
Table 86. CAHIC Company Information
Table 87. CAHIC Business Overview
Table 88. CAHIC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. CAHIC Veterinary Vaccine Product Portfolio
Table 90. CAHIC Recent Development
Table 91. HVRI Company Information
Table 92. HVRI Business Overview
Table 93. HVRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 94. HVRI Veterinary Vaccine Product Portfolio
Table 95. HVRI Recent Development
Table 96. Ringpu Biology Company Information
Table 97. Ringpu Biology Business Overview
Table 98. Ringpu Biology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 99. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 100. Ringpu Biology Recent Development
Table 101. Yebio Company Information
Table 102. Yebio Business Overview
Table 103. Yebio Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 104. Yebio Veterinary Vaccine Product Portfolio
Table 105. Yebio Recent Development
Table 106. DHN Company Information
Table 107. DHN Business Overview
Table 108. DHN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 109. DHN Veterinary Vaccine Product Portfolio
Table 110. DHN Recent Development
Table 111. WINSUN Company Information
Table 112. WINSUN Business Overview
Table 113. WINSUN Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 114. WINSUN Veterinary Vaccine Product Portfolio
Table 115. WINSUN Recent Development
Table 116. Elanco Company Information
Table 117. Elanco Business Overview
Table 118. Elanco Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 119. Elanco Veterinary Vaccine Product Portfolio
Table 120. Elanco Recent Development
Table 121. Virbac Company Information
Table 122. Virbac Business Overview
Table 123. Virbac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 124. Virbac Veterinary Vaccine Product Portfolio
Table 125. Virbac Recent Development
Table 126. Jinyu Bio-Technology Company Information
Table 127. Jinyu Bio-Technology Business Overview
Table 128. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 129. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 130. Jinyu Bio-Technology Recent Development
Table 131. ChengDu Tecbond Company Information
Table 132. ChengDu Tecbond Business Overview
Table 133. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 134. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 135. ChengDu Tecbond Recent Development
Table 136. CAVAC Company Information
Table 137. CAVAC Business Overview
Table 138. CAVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 139. CAVAC Veterinary Vaccine Product Portfolio
Table 140. CAVAC Recent Development
Table 141. Kyoto Biken Laboratories Company Information
Table 142. Kyoto Biken Laboratories Business Overview
Table 143. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 144. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 145. Kyoto Biken Laboratories Recent Development
Table 146. FATRO Company Information
Table 147. FATRO Business Overview
Table 148. FATRO Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 149. FATRO Veterinary Vaccine Product Portfolio
Table 150. FATRO Recent Development
Table 151. Vaksindo Company Information
Table 152. Vaksindo Business Overview
Table 153. Vaksindo Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 154. Vaksindo Veterinary Vaccine Product Portfolio
Table 155. Vaksindo Recent Development
Table 156. Bio-Labs Company Information
Table 157. Bio-Labs Business Overview
Table 158. Bio-Labs Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 159. Bio-Labs Veterinary Vaccine Product Portfolio
Table 160. Bio-Labs Recent Development
Table 161. Avimex Animal Health Company Information
Table 162. Avimex Animal Health Business Overview
Table 163. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 164. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 165. Avimex Animal Health Recent Development
Table 166. MEVAC Company Information
Table 167. MEVAC Business Overview
Table 168. MEVAC Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 169. MEVAC Veterinary Vaccine Product Portfolio
Table 170. MEVAC Recent Development
Table 171. Biovac Company Information
Table 172. Biovac Business Overview
Table 173. Biovac Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 174. Biovac Veterinary Vaccine Product Portfolio
Table 175. Biovac Recent Development
Table 176. Atafen Company Information
Table 177. Atafen Business Overview
Table 178. Atafen Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 179. Atafen Veterinary Vaccine Product Portfolio
Table 180. Atafen Recent Development
Table 181. Dyntec Company Information
Table 182. Dyntec Business Overview
Table 183. Dyntec Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 184. Dyntec Veterinary Vaccine Product Portfolio
Table 185. Dyntec Recent Development
Table 186. BioTestLab Company Information
Table 187. BioTestLab Business Overview
Table 188. BioTestLab Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 189. BioTestLab Veterinary Vaccine Product Portfolio
Table 190. BioTestLab Recent Development
Table 191. RVSRI Company Information
Table 192. RVSRI Business Overview
Table 193. RVSRI Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 194. RVSRI Veterinary Vaccine Product Portfolio
Table 195. RVSRI Recent Development
Table 196. Medion Company Information
Table 197. Medion Business Overview
Table 198. Medion Veterinary Vaccine Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 199. Medion Veterinary Vaccine Product Portfolio
Table 200. Medion Recent Development
Table 201. Key Raw Materials
Table 202. Raw Materials Key Suppliers
Table 203. Veterinary Vaccine Distributors List
Table 204. Veterinary Vaccine Customers List
Table 205. Research Programs/Design for This Report
Table 206. Authors List of This Report
Table 207. Secondary Sources
Table 208. Primary Sources
LIST OF FIGURES
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Veterinary Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Veterinary Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Veterinary Vaccine Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Live Attenuated Vaccines Picture
Figure 9. Inactivated Vaccines Picture
Figure 10. Others Picture
Figure 11. Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Veterinary Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
Figure 14. Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Veterinary Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
Figure 17. Livestock Picture
Figure 18. Swine Picture
Figure 19. Chicken Picture
Figure 20. Dog & Cat Picture
Figure 21. Others Picture
Figure 22. Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Veterinary Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 24. Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
Figure 25. Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 26. Global Veterinary Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 27. Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
Figure 28. North America Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. North America Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 30. U.S. Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. Canada Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. Europe Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Europe Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 34. Germany Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. France Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. U.K. Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Italy Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Netherlands Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Asia Pacific Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Asia Pacific Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 41. China Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Japan Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. South Korea Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. Southeast Asia Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. India Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Australia Veterinary Vaccine Sales and Growth Rate
Figure 1. Veterinary Vaccine Product Picture
Figure 2. Global Veterinary Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Veterinary Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Veterinary Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Veterinary Vaccine Average Price (USD/Doses) & (2019-2030)
Figure 6. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Live Attenuated Vaccines Picture
Figure 9. Inactivated Vaccines Picture
Figure 10. Others Picture
Figure 11. Global Veterinary Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Veterinary Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
Figure 14. Global Veterinary Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 15. Global Veterinary Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
Figure 17. Livestock Picture
Figure 18. Swine Picture
Figure 19. Chicken Picture
Figure 20. Dog & Cat Picture
Figure 21. Others Picture
Figure 22. Global Veterinary Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Veterinary Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 24. Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
Figure 25. Global Veterinary Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 26. Global Veterinary Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 27. Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
Figure 28. North America Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 29. North America Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 30. U.S. Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 31. Canada Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 32. Europe Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 33. Europe Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 34. Germany Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 35. France Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 36. U.K. Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 37. Italy Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 38. Netherlands Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 39. Asia Pacific Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 40. Asia Pacific Veterinary Vaccine Sales Market Share by Country (2019-2030)
Figure 41. China Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 42. Japan Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 43. South Korea Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 44. Southeast Asia Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 45. India Veterinary Vaccine Sales and Growth Rate (2019-2030) & (M Doses)
Figure 46. Australia Veterinary Vaccine Sales and Growth Rate
